Building on recent genetic discoveries, Julie Snowden (University of Manchester, UK) showed the relationship between the diverse clinical characteristics and the underlying pathologies of frontotemporal dementia (FTD) (tau, TDP-43 and FUS) and associated genetic mutations (MAPT, C9orf72 and GRN). The gene discussed is MAPT; the disease is frontotemporal dementia.